Crohn’s Disease Associated Pyoderma Gangrenosum Treated with Adalimumab

Pyoderma gangrenosum is a known, though infrequent, ulcerative skin lesion that is often associated with systemic inflammatory and immunologic diseases. Objective: To present the efficacy of Adalimumab, a fully human Tumour Necrosis Factor-α antagonist, in the treatment of pyoderma gangrenosum assoc...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Balkan Medical Journal
المؤلفون الرئيسيون:	Despoina Kakagia, Eleni Efremidou, Nikolaos Lyratzopoulos, Alexandros Mitrakas, Michael Pitiakoudis, George Kouklakis
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Trakya University 2012-03-01
الموضوعات:	Adalimumab Crohn’s disease immunomodulating agents pyoderma gangrenosum
الوصول للمادة أونلاين:	http://www.tutfd.org/text.php3?id=838